F2G
F2G discovers and develops novel drugs for the treatment of life-threatening fungal diseases
F2G has raised €211M across 5 funding rounds from 18 investors, most recently a round in Aug 2022. Based in Eccles, UK; founded 1998; active in Healthtech. Data as of 28 Oct 2026.
Total raised
€211M
€210,655,287
Funding rounds
5
Investors
18
distinct backers
Active since
2008-08
latest 2022-08
Funding by year
EUR raised per yearF2G — funding by year — interactive chart.
Data table
| F2G — funding by year | |
|---|---|
| 2008 | €8.8M |
| 2012 | €27M |
| 2016 | €55M |
| 2020 | €52M |
| 2022 | €69M |
Signals
High confidenceRaise-next likelihood6
base rate 30% for Other
- ▼ Dormant (no round in 3+ cohort gaps)
- ▲ Up-round momentum
- ▼ Low backer re-investment
Exit likelihood7
base rate 11% (2+ rounds)
- ▲ €100M+ raised
- ▲ 5 rounds raised
- ▼ Old (28y) — past typical exit age
- ▼ No recent equity round (debt-only or quiet)
Timing: dormant vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
5 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2022-08-04 | Other | €69M | Advent Life Sciences,Cowen Healthcare Investments,Forbion,Morningside Ventures,Novo Holdings,Sofinnova Partners | View deal → |
| 2020-08-12 | Other | €52M | Cowen Healthcare Investments | View deal → |
| 2016-06-01 | Growth/Late | €55M | Advent Venture Partners,Aisling Capital,Brace Pharma,Merifin Capital,Novartis Venture Fund,Novo A+3 more | View deal → |
| 2012-09-01 | Growth/Late | €27M | Advent Venture Partners,Astellas Venture Management,K Nominees,Merifin Capital,Novartis Venture Fund,Sunstone Capital | View deal → |
| 2008-08-01 | Early VC | €8.8M | Astellas Venture Management,BankInvest,K Nominees,Merifin Capital | View deal → |
Investors
18Related news
- F2G Raises $70M in Financingfinsmes.com · 2022-08
- finsmes.com
- finsmes.com
Similar companies
same sector or countryGlobal coverage: FundingData